EFOUI ABOTSI-KOWU: Open Payments
NPI 1609431220 · YUMA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$703 in 20 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $703
Food & beverage: $703
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $232 |
| ABBVIE INC. | 6 | $193 |
| Madrigal Pharmaceuticals | 2 | $149 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $92 |
| GENZYME CORPORATION | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
Products named: TREMFYA, REZDIFFRA, SKYRIZI, ENTYVIO, RINVOQ, DUPIXENT, ZENPEP.
Industry payments across AZ — which companies pay providers there.
